Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01737593 · ClinicalTrials.gov registry record · Phase 4

Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?

A Phase 4 study, sponsored by University of California, Los Angeles.

Terminated
Registry status
Phase 4
Development phase
108
Enrollment target

NCT01737593: Clinical Trial Phase 4 study, sponsored by University of California, Los Angeles.

NCT01737593 is a Phase 4 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 108 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01737593, a Phase 4 study, was terminated before completion, sponsored by University of California, Los Angeles.

TERMINATED
Registry status
Phase 4
Development phase
108 participants
Enrollment target

Study Summary

Emergence agitation (EA) occurs in up to 67% of pediatric patients after anesthesia for bilateral myringotomy tubes (BMT, "ear tubes"). The goal of this study is to find out whether acetaminophen given well before surgery can decrease pain and therefore, decrease emergence agitation better than acetaminophen given shortly before or during surgery. EA can be dangerous for the patient because it may be hard to monitor their vital signs during an important phase of recovery, they may injure themselves, may require the presence of extra staff, and it can be very distressing to the parents. Causes of EA are not well understood, but it can be worsened by pain. 70% of patients undergoing BMT experience pain that needs treatment. Intranasal fentanyl, a strong analgesic, has been shown to decrease EA, but often ends up in dose-dependent nausea and vomiting. In previous studies and in common practice, acetaminophen is given either 30 minutes before induction of anesthesia or immediately after induction. The peak analgesic effect of acetaminophen is 60-120 minutes. Since the procedure is generally completed in 5-10 minutes, the therapeutic effect of acetaminophen may not be present upon emergence from anesthesia. The purpose of this study is to find out if acetaminophen given 60-120 minutes prior to emergence can decrease EA in patients undergoing BMT. Patients would be randomized to one of three groups: Control will receive acetaminophen rectally while under anesthesia (standard practice), Group 1 will receive acetaminophen 10 mg/kg at 60-120 minutes prior to surgery, Group 2 will receive acetaminophen 20 mg/kg at 60-120 minutes prior to surgery. All groups would also receive a dose of intranasal fentanyl during the surgery, which is standard practice. Patients would be observed in the recovery room at various time points for evidence of EA and pain.

Primary Outcome

EA was evaluated using the Pediatric Anesthesia Emergence Delirium (PAED) scale. This scale measures if the: 1. Child makes eye contact with the caregiver, 2. Child's actions are purposeful, 3. Child is aware of his/her surroundings, 4. Child is restless, 5. Child is inconsolable. Items 1, 2, and 3 are reversed scored as follows: 4 \_ not at all, 3 \_ just a little, 2 \_ quite a bit, 1 \_ very much, 0 \_ extremely. Items 4 and 5 are scored as follows: 0 \_ not at all, 1 \_ just a little, 2 \_ q

Interventions

  • DRUG Acetaminophen

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2012-11
Est. Completion 2014-04
Phase Phase 4

Why NCT01737593 stopped before completion

NCT01737593 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which Acetaminophen is the first listed.

NCT01737593 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01737593 about?

NCT01737593 is a clinical study titled "Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?". Emergence agitation (EA) occurs in up to 67% of pediatric patients after anesthesia for bilateral myringotomy tubes (BMT, "ear tubes"). The goal of this study is to find out whether acetaminophen given well before surgery can decrease pain and therefore, decrease emergence agitation better than acet...

What is the current status of trial NCT01737593?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 108 participants. The study started on 2012-11. Estimated completion is 2014-04.

What interventions are being tested in trial NCT01737593?

The interventions under investigation include: Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT01737593?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01737593's enrollment target sits among peer trials

108 740th of 2000 higher than 1,256 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01737593, the US trial registry maintained by the National Library of Medicine. NCT01737593 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.